Press releaseGlobe Newswire
Cocrystal Pharma
COCP · NASDAQ
$0.9429−$0.0037 (−0.39%)TodayMarket closed ·
Prev close $0.9466
Latest news
- Press releaseGlobe Newswire
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
- Press releaseGlobe Newswire
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
- Press releaseGlobe Newswire
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
- News
Watching Cocrystal Pharma; Zacks-Small Cap Research Gives Stock $8 Price Valuation
- Press releaseGlobe Newswire
Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
- Press releaseGlobe Newswire
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
- NewsKaustubh Bagalkote
Why Cocrystal Pharma Shares Are Cooling Off Monday?
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- NewsAvi Kapoor
Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Nasdaq Down 1%; US Initial Jobless Claims Fall
- NewsDylan Berman
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
Cocrystal Pharma Says FDA Grants Fast Track Designation To Its Direct-Acting Protease Inhibitor, CDI-988, Oral Antiviral Candidate Being Developed For Treatment And Prophylaxis Of Norovirus Infection
- Press releaseGlobe Newswire
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseGlobe Newswire
Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
- NewsAvi Kapoor
Dow Dips Over 100 Points; Cocrystal Pharma Shares Slide
- NewsAvi Kapoor
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet
- NewsAvi Kapoor
US Stocks Open Higher; House Prices Increase In October
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Toll Brothers To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.